Editor’s Choice: Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant

Editorial: Does a diagnosis of breast cancer reduce ovarian cancer risk in BRCA1/2 carriers:Why is this a question?


Hosted by:
John Farley, MD, COL(ret), FACOG, FACS, St Joseph's Hospital and Medical Center, Phoenix, AZ, United States of America

Featuring:
Steven Narod, Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada
Stephanie Blank, Icahn School of Medicine at Mount Sinai,  New York, NY, USA
Melissa K. Frey, Weill Cornell Medicine, New York, NY, USA

Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Gynecologic Oncology. Innehållet i podden är skapat av Gynecologic Oncology och inte av, eller tillsammans med, Poddtoppen.